You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Microscale Detector Materials for Covert, Ubiquitous Radiation Detector

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: DTRA14B004

    The proliferation of nuclear and radiological weapons of mass destruction is a serious threat in the world today. The goal of this proposal is to develop a new, very low cost radiation detection technology that will be useful for detection and for surveillance of individuals who have been near radioactive materials. The technology can also be used for dosimetry, and will provide the technology for ...

    STTR Phase I 2015 Department of DefenseDefense Threat Reduction Agency
  2. Large area, high efficiency, extremely light-weight portable neutron Detector

    SBC: TRITON SYSTEMS, INC.            Topic: DTRA14B005

    A drop-in 3He-tube replacement technology for thermal neutron detection does not exist today. It is critical for homeland security and nuclear safeguards applications. In this program, Triton Systems proposes to develop a light-weight, large-area, high efficiency portable neutron detector for passive interrogation using an innovative gas detector structure. The resulting 3He-free thermal neutron d ...

    STTR Phase I 2015 Department of DefenseDefense Threat Reduction Agency
  3. Improved Performance of Neonatal Vascular Access Catheters via 3D Magnetic Printing

    SBC: N2 Biomedical, LLC            Topic: NICHD

    DESCRIPTION provided by applicant Clinical treatment of infants in the neonatal intensive care unit NICU is particularly challenging due to their small anatomies medical instability and immature physiological processes Treatment is often complicated by the lack of therapeutic devices and instrumentation designed specifically to accommodate this unique patient population For instance curr ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  4. HLS13-13 Albumin nanoparticle based technology to treat ARDS

    SBC: CELL BIOLOGICS INC            Topic: NHLBI

    DESCRIPTION provided by applicant Severe infections various types of trauma and other etiologic factors can cause ALI that rapidly morphs into ARDS The incidence of ALI ARDS is around in adults in US alone Despite medical advances and better management through ventilation intervention the mortality is still unacceptably high at This problem is likely to escalate given the a ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  5. Mapping electrogram morphology recurrence for atrial fibrillation ablation

    SBC: GOLD T-TECH, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant Atrial fibrillation AF is the most common diagnosed arrhythmia with the number Americans diagnosed with AF estimated at million and continuing to increase as the population ages Electrical activity during AF is characterized by complex activation patterns that are difficult to map However there is growing evidence that AF is driven by stable sources i ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  6. Identification of patients with diabetes at high risk for treatment failure

    SBC: LP INFORMATION TECHNOLOGY INC.            Topic: 200

    DESCRIPTION provided by applicant The overall goal of this project is to improve quality of care of patients with diabetes by identifying patients who may have particular difficulty reaching treatment targets and who could therefore potentially benefit from additional resources Investigators propose to achieve this goal by developing a technology to accurately identify patients at high risk f ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Portable Multimode Persufflation/Perfusion System for Extended Hypothermic Kidney Preservation

    SBC: GINER INC            Topic: NIDDK

    DESCRIPTION provided by applicant Portable Multimode Persufflation Perfusion System for Extended Hypothermic Kidney Preservation In over patients in the US started treatment for end stage renal disease ESRD These patients spend on average $ annually on treatment including dialysis In The U S the current waiting list for organ transplantation holds over patient ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  8. A novel drug detection assay using fluorescent biosensor technology

    SBC: GLSynthesis Inc.            Topic: 300

    DESCRIPTION provided by applicant This phase project has as its overall objectives to design engineer optimize and implement a novel genetically encoded fluorescent drug sensor FDS based on F rster Resonance Energy Transfer FRET by exploiting conformational rearrangements induced by drug interactions with human serum albumin SA SA is uniquely suited for a general drug sensor beca ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. ASTROCYTE ACTIVATION BY SMALL MOLECULE P2Y1 AGONISTS FOR TREATMENT OF TBI

    SBC: ASTROCYTE PHARMACEUTICALS INC.            Topic: 105

    DESCRIPTION provided by applicant Traumatic brain injuries TBI are an area of significant unmet need with no approved therapeutics and a national burden of $ billion annually Astrocyte Pharmaceuticals is developing a small molecule pharmaceutical agent that would be administered by intravenous injection by emergency responders or a medical professional within hours of injury to limit n ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Development of PAR2 Pepducins for the Treatment of Atopic Dermatitis

    SBC: OASIS PHARMACEUTICALS, LLC            Topic: NIAMS

    DESCRIPTION provided by applicant Atopic dermatitis AD or severe eczema is a very common life long skin disease with of adults in the US requiring systemic therapy Clinical manifestations of AD include multiple inflamed lesions erosions accompanied by lichenification thick leathery skin fibrotic papules and severely dry skin with increased susceptibility to infection A major uncont ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government